Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review

9Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

We herein report two cases of coronavirus disease 2019 (COVID-19) vaccine-induced immune thrombocytopenia (ITP). A 69-year-old Japanese man developed severe thrombocytopenia after COVID-19 vaccination. He had oral bleeding and hemoptysis but no thrombotic symptoms. He improved rapidly with oral prednisolone therapy. A 34-year-old Japanese woman had generalized purpura after COVID-19 vaccination. Her platelet count improved rapidly after treatment with prednisolone and eltrombopag. The occurrence of two cases of ITP after COVID-19 vaccination at a single institution suggests that there could be more such undiagnosed cases, especially cases of mild secondary ITP.

Cite

CITATION STYLE

APA

Shonai, T., Kimura, F., & Watanabe, J. (2022). Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review. Internal Medicine. Japanese Society of Internal Medicine. https://doi.org/10.2169/internalmedicine.9177-21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free